The board of directors of Johnson & Johnson (NYSE:JNJ) authorised a common stock cash dividend of USD1.01 per share for the first quarter of 2021, the company reported on Monday.
With an ex-dividend date of 22 February 2021, the dividend will be paid on 9 March 2021 to shareholders of record at the close of business on 23 February 2021.
Johnson & Johnson researches and develops, manufactures and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical and Medical Devices.
The company was founded in 1886 and is based in New Brunswick, New Jersey, USA.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project